Significant incidence of braf p.V600E mutations in esophageal cancer sets the stage for potential use of tyrosine kinase inhibitors
Loading...
Files
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Jaffna Medical Association
Abstract
Description
Citation
Proceedings JMA-September - 2020